Results 61 to 70 of about 2,761,482 (311)

A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.

Cancer Research, 2015
Ductal carcinoma in situ (DCIS) is a noninvasive precursor lesion to invasive breast carcinoma. We still have no understanding on why only some DCIS lesions evolve to invasive cancer whereas others appear not to do so during the life span of the patient.
M. Abba, Ting Gong, Yue Lu, Jaeho Lee, Y. Zhong, E. Lacunza, M. Butti, Y. Takata, S. Gaddis, Jianjun Shen, M. Estecio, A. Sahin, Claudio Marcelo Aldaz   +12 more
semanticscholar   +1 more source

Predicting invasive ductal carcinoma using a Reinforcement Sample Learning Strategy using Deep Learning [PDF]

arXiv, 2021
Invasive ductal carcinoma is a prevalent, potentially deadly disease associated with a high rate of morbidity and mortality. Its malignancy is the second leading cause of death from cancer in women. The mammogram is an extremely useful resource for mass detection and invasive ductal carcinoma diagnosis.
arxiv  

In situ quantification of genomic instability in breast cancer progression [PDF]

, 2003
Genomic instability is a hallmark of breast and other solid cancers. Presumably caused by critical telomere reduction, GI is responsible for providing the genetic diversity required in the multi-step progression of the disease. We have used multicolor
Chin, Koei, Gray, Joe W., Lockett, Stephen J., Ortiz de Solorzano, Carlos   +3 more
core   +1 more source

Designing for Degradation: Transient Devices Enabled by (Nano)Cellulose

Advanced Materials, EarlyView.
Recent progress in transient devices enabled by (nano)cellulosic materials is reviewed. Transiency mechanisms, advantages of nanocelluloses, and a suite of applications are discussed. A circular thinking approach coupled with life cycle assessment is applied to critically revisit the potential, advantages, and challenges of nanocellulose‐enabled ...
Lucas J. Andrew, Erlantz Lizundia, Mark J. MacLachlan   +2 more
wiley   +1 more source

Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan [PDF]

, 2005
INTRODUCTION: Although breast carcinoma (BC) is the most common malignancy affecting Jordanian females and the affected population in Jordan is younger than that in the West, no information is available on its biological characteristics. Our aims in this
AA Abalkhail, AM Ruder, B Zafrani, CR De Potter, CW Elston, D Varshney, DC Allred, DH Choi, DJ Slamon, DJ Slamon, DJ Slamon, E May, Early Breast Cancer Trialists' Collaborative Group, ER Hoff, F Revillion, G Abadjian, G Arpino, G Pauletti, G Pauletti, GN Hortobagyi, HB Muss, J Ashba, J Yang, JA Ligibel, JM Esteban, Jordan Cancer Registry, Ministry of Health, JS Huston, JS Ross, K McKeage, LC Hartmann, LJ Layfield, LK Shawver, M Ferno, M Stierer, MF Kamal, Mohammad Al Hamad, Nidal M Almasri, O Stal, PL Porter, RH Mohammed, S Chariyalertsak, S Eppenberger-Castori, S Paik, S Taucher, SI Rosenthal, SS Amr, T el-A Helal, T Rajkumar, U Berger, W Hanna, WF Anderson, YF Dajani   +51 more
core   +2 more sources

Progress and Application of Multifunctional Hydrogel in Radioactive Skin Injury

Advanced Materials Interfaces, EarlyView.
This review examines healing challenges in radiation‐wound injuries, where ionizing radiation impairs immune and tissue repair processes. Hydrogels, with their biocompatibility, antimicrobial properties, and drug delivery capabilities, present a transformative solution. It compares hydrogel efficacy in radiation‐induced versus common wounds, highlights
Xinyue Cui, Jingyi Wang, Xinyi Xu, Xiqian Cao, Yingtang Zhou, Jiaming Guo   +5 more
wiley   +1 more source

Hybrid Classic-Quantum Computing for Staging of Invasive Ductal Carcinoma of Breast [PDF]

arXiv, 2023
Despite the great current relevance of Artificial Intelligence, and the extraordinary innovations that this discipline has brought to many fields -among which, without a doubt, medicine is found-, experts in medical applications of Artificial Intelligence are looking for new alternatives to solve problems for which current Artificial Intelligence ...
arxiv  

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy [PDF]

, 2018
© Springer-Verlag GmbH Germany, part of Springer Nature 2018Background: Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer improves all-cause and cancer specific survival.
A Takayanagi, A. J. Stephenson, A. S. Fairey, A. Thorpe, B. W. van Rhijn, BG Volkmer, C. E. Ercole, C. P. Dinney, CJ Weight, CP Dinney, CP Dinney, D Liu, D. A. Barocas, DC Chade, DE Thomas, E. Xylinas, E. Y. Yu, EM Allen Van, ER Plimack, ER Seiler Plimack, H Zargar, H Zargar, H. Zargar, HB Grossman, J. A. Seah, J. Aning, J. B. Shah, J. Griffin, J. L. Wright, J. M. Holzbeierlein, J. P. Noël, J. S. McGrath, J. S. Montgomery, JB Kukreja, L. M. Krabbe, L. S. Mertens, M. A. Dall’Era, M. C. Mir, M. S. Cookson, MA Knowles, N. E. Jacobsen, N. J. Campain, N. M. Gandhi, N. Vasdev, P. C. Black, P. E. Spiess, P. Grivas, R. Veeratterapillay, S Masood, S. Daneshmand, S. F. Shariat, S. Horenblas, S. North, S. S. Sridhar, T. J. Bivalacqua, T. M. Morgan, TJN Hermans, W Choi, W Choi, W. Kassouf, WP Parker, Y. Lotan   +61 more
core   +1 more source

Progress in Surface Plasmon and Other Resonance Biosensors for Biomedical Applications

Advanced Materials Technologies, EarlyView.
This is the shortened version: Recent advancements in surface plasmon resonance and other optical resonance biosensors for biomedical applications are presented. Advanced sensing strategies are examined for the detection of diverse analytes, integration of nanomaterials and machine learning, and emerging nonplasmonic modes like guided mode resonance ...
Faten Bashar Kamal Eddin, Houxin Fan, Zhenchao Liu, Paolo Donati, Youssef Amin, Yap Wing Fen, Junbo Liang, Pier Paolo Pompa, Sailing He   +8 more
wiley   +1 more source

Modelo de Tratamiento para Tumores en Presencia de Radiación [PDF]

arXiv, 2017
In this work, we combine a new form of the cell survival fraction developed in [29] with the Gompertz cell growth model. The result is an equation that models the cell growth/death under a radiation dose and can be applied in a conventional radiation treatment (we chose conventional fractionation and hypofractionation).
arxiv